| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.20B | $1.30B | $804.0M |
| YoY Revenue Growth % | +69.4% | +61.7% | — |
| Gross Profit | $2.01B | $1.18B | — |
| Gross Margin % | 91.2% | 90.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $442.0M | -$560.6M | -$140.2M |
| Operating Margin % | 20.1% | -43.1% | -17.4% |
| Net Income (GAAP) | $530.0M | -$484.0M | -$90.8M |
| EBITDA (Normalized) | $447.3M | -$555.6M | -$111.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $690.9M | $222.1M | -$75.1M |
| Capital Expenditures (CapEx) | $6.7M | $6.2M | $36.2M |
| Free Cash Flow (FCF) | $684.2M | $215.8M | -$111.3M |
| FCF Margin % | 31.1% | 16.6% | -13.8% |
| Return on Invested Capital (ROIC %) | 16.5% | -26.7% | -1.3% |
| Cash & Short-Term Equivalents | $953.6M | $562.1M | — |
| Total Debt (Short + Long Term) | $139.6M | $92.6M | $3.21B |
| Total Stockholders' Equity | $2.93B | $2.13B | $6.58B |